Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment-resistant depression in secondary community mental health services: trial protocol

被引:2
|
作者
Stefanidou, Theodora [1 ]
Ambler, Gareth [2 ,3 ]
Bartl, Gergely [1 ]
Barber, Nick [1 ,4 ]
Billings, Jo [1 ]
Bogatsu, Tumelo [5 ]
Carroll, Richard [6 ]
Chipp, Beverley [1 ,4 ]
Conneely, Maev [1 ]
Downey, Anne-Marie [3 ]
Evlat, Gamze [1 ,7 ]
Hunter, Rachael [3 ,8 ]
Le Novere, Marie [3 ,8 ]
Lewis, Glyn [1 ,3 ,7 ]
Mackay, Tanya [4 ]
Marwaha, Steven [5 ]
Matin, Zubair [1 ]
Naughton, Georgia [4 ]
Nekitsing, Chandani [9 ]
O'Sullivan, Millie [1 ,7 ]
Pinfold, Vanessa [4 ]
Pan, Shengning [2 ,3 ]
Sobers, Angela [10 ]
Thompson, Keith J. [4 ,6 ]
Vasikaran, Jerusaa [1 ]
Webber, Martin [9 ]
Johnson, Sonia [1 ,7 ]
Lloyd-Evans, Brynmor [1 ]
机构
[1] UCL, Div Psychiat, Maple House,149 Tottenham Court Rd, London W1T 7NF, England
[2] UCL, Dept Stat Sci, London, England
[3] UCL, Priment Clin Trials Unit, London, England
[4] McPin Fdn, London, England
[5] Univ Birmingham, Inst Mental Hlth, Birmingham, England
[6] NHS Fdn Trust, Tees Esk & Wear Valley, Durham, England
[7] Camden & Islington NHS Fdn Trust, London, England
[8] UCL, Dept Primary Care & Populat Hlth, London, England
[9] Univ York, Sch Business & Soc, York, England
[10] NHS Mental Hlth Trust, Barnet Enfield & Haringey, London, England
关键词
Loneliness; Depression; Community navigator; Randomised controlled trial; STAR-ASTERISK-D; LONG-TERM; SCALE; CARE; DISORDER; VALIDITY; OUTCOMES; ANXIETY; PEOPLE; PHQ-9;
D O I
10.1186/s13063-023-07684-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundNew treatments are needed for people with treatment-resistant depression (TRD), who do not benefit from anti-depressants and many of whom do not recover fully with psychological treatments. The Community Navigator programme was co-produced with service users and practitioners. It is a novel social intervention which aims to reduce loneliness and thus improve health outcomes for people with TRD. Participants receive up to 10 individual meetings with a Community Navigator, who helps them to map their social world and set and enact goals to enhance their social connections and reduce loneliness. Participants may also access group meet-ups with others in the programme every 2 months, and may be offered modest financial support to enable activities to support social connections.MethodsA researcher-blind, multi-site, 1:1 randomised controlled trial with N = 306 participants will test the effectiveness of the Community Navigator programme for people with TRD in secondary community mental health teams (CMHTs). Our primary hypothesis is that people who are offered the Community Navigator programme as an addition to usual CMHT care will be less depressed, assessed using the PHQ-9 self-report measure, at 8-month, end-of-treatment follow-up, compared to a control group receiving usual CMHT care and a booklet with information about local social groups and activities. We will follow participants up at end-of-treatment and at 14 months, 6 months after end-of-treatment follow-up. Secondary outcomes include the following: loneliness, anxiety, personal recovery, self-efficacy, social network, social identities. We will collect data about health-related quality of life and service use to investigate the cost-effectiveness of the Community Navigator programme.DiscussionThis trial will provide definitive evidence about the effectiveness and cost-effectiveness of the Community Navigator programme and whether it can be recommended for use in practice. The trial is due to finish in August 2025.Trial registrationProspectively registered on 8th July 2022 at: ISRCTN13205972.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
    Husain, Muhammad I.
    Chaudhry, Imran B.
    Rahman, Raza R.
    Hamirani, Munir M.
    Qurashi, Inti
    Khoso, Ameer B.
    Deakin, John F. W.
    Husain, Nusrat
    Young, Allan H.
    TRIALS, 2015, 16
  • [42] Cluster randomised controlled trial of a problem-solving, Story-bridge mental health literacy programme for improving Ghanaian community leaders' knowledge of depression
    Arthur, Yaw Amankwa
    Boardman, Gayelene H.
    Morgan, Amy J.
    McCann, Terence, V
    JOURNAL OF MENTAL HEALTH, 2023, 31 (06) : 748 - 756
  • [43] Longitudinal Outcomes of Resilience, Quality of Life, and Community Integration in Treatment-Resistant Depression: A Two-Group Matched Controlled Trial
    Wu, Chia-Yi
    Lee, Ming-Been
    Huong, Pham Thi Thu
    Chen, I-Ming
    Chen, Hsi-Chung
    Hsieh, Min-Hsien
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2024, 30 (04) : 765 - 777
  • [44] The Effectiveness of an Online Support Group for Members of the Community with Depression: A Randomised Controlled Trial
    Griffiths, Kathleen M.
    Mackinnon, Andrew J.
    Crisp, Dimity A.
    Christensen, Helen
    Bennett, Kylie
    Farrer, Louise
    PLOS ONE, 2012, 7 (12):
  • [45] Neurocognitive Effects of Ketamine in Individuals with Treatment-resistant Depression: A Randomized Controlled Trial
    Murrough, James
    Burdick, Katherine
    Perez, Andrew
    Brallier, Jess
    Chang, Lee
    Foulkes, Alexander
    Charney, Dennis
    Mathew, Sanjay
    Iosifescu, Dan
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S391 - S391
  • [46] Reablement in community-dwelling adults: study protocol for a randomised controlled trial
    Hanne Tuntland
    Birgitte Espehaug
    Oddvar Forland
    Astri Drange Hole
    Egil Kjerstad
    Ingvild Kjeken
    BMC Geriatrics, 14
  • [47] Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    van Asselt, Antoinette D. I.
    Touw, Daan J.
    aan Het Rot, Marije
    Schoevers, Robert A.
    BMC PSYCHIATRY, 2019, 19 (01)
  • [48] Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol
    Eisendrath, Stuart J.
    Gillung, Erin P.
    Delucchi, Kevin L.
    Chartier, Maggie
    Mathalon, Daniel H.
    Sullivan, Jude C.
    Segal, Zindel V.
    Feldman, Mitchell D.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [49] Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial
    Galvez, Veronica
    Li, Adrienne
    Huggins, Christina
    Glue, Paul
    Martin, Donel
    Somogyi, Andrew A.
    Alonzo, Angelo
    Rodgers, Anthony
    Mitchell, Philip B.
    Loo, Colleen K.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (04) : 397 - 407
  • [50] EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
    Price, Rebecca B.
    Iosifescu, Dan V.
    Murrough, James W.
    Chang, Lee C.
    Al Jurdi, Rayan K.
    Iqbal, Syed Z.
    Soleimani, Laili
    Charney, Dennis S.
    Foulkes, Alexandra L.
    Mathew, Sanjay J.
    DEPRESSION AND ANXIETY, 2014, 31 (04) : 335 - 343